Zhang, Meili <br/><br/>
Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Feb 2003 
 - 1891-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.0437788100  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Leukemia--radiotherapy<br/>Lymphoma--radiotherapy<br/>Mice<br/>Radioimmunotherapy<br/>Receptors, Interleukin-2--immunology<br/>Recombinant Fusion Proteins--immunology<br/>Streptavidin--immunology<br/>Transplantation, Heterologous